| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.04 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.33 | 0.04 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.21 | 0.04 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.05 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.056 | 0.05 |